Interview with Isabelle Ducellier on Pharma Boardroom

The website has published an interview with BioGaia’s CEO Isabelle Ducellier, in which she, among other things, talks about the importance of strain specificity in the probiotic field, BioGaia’s serious approach to science and the role of probiotics in the fight of antibiotic resistance. covers global pharma/healthcare news and has more than 46,000 monthly visitors, many of them policy-makers, senior executives and other key persons in the sector.​ Read the article here.